Cargando…
Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer
WBP2 transcription coactivator is an emerging oncoprotein and a key node of convergence between EGF and Wnt signaling pathways. Understanding how WBP2 is regulated has important implications for cancer therapy. WBP2 is tightly controlled by post-translational modifications, including phosphorylation...
Autores principales: | Lim, Shen Kiat, Tabatabaeian, Hossein, Lu, Ssu Yi, Kang, Shin-Ae, Sundaram, Gopinath Meenakshi, Sampath, Prabha, Chan, Siew Wee, Hong, Wan Jin, Lim, Yoon Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441404/ https://www.ncbi.nlm.nih.gov/pubmed/32820148 http://dx.doi.org/10.1038/s41419-020-02901-3 |
Ejemplares similares
-
The emerging roles of WBP2 oncogene in human cancers
por: Tabatabaeian, Hossein, et al.
Publicado: (2020) -
WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex
por: Tabatabaeian, Hossein, et al.
Publicado: (2021) -
Reciprocal Regulation of Hippo and WBP2 Signalling—Implications in Cancer Therapy
por: Lim, Yvonne Xinyi, et al.
Publicado: (2021) -
WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ
por: Chan, S W, et al.
Publicado: (2011) -
Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2
por: Loforese, Giulio, et al.
Publicado: (2016)